Elanco Animal Health Incorporated (ELAN)
| Market Cap | 15.55B |
| Revenue (ttm) | 3.86B |
| Net Income (ttm) | -572.00M |
| Shares Out | 486.70M |
| EPS (ttm) | -1.27 |
| PE Ratio | n/a |
| Forward PE | 32.79 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 7 |
| Last Price | $32.88 |
| Previous Close | $31.05 |
| Change ($) | 1.83 |
| Change (%) | 5.89% |
| Day's Open | 32.60 |
| Day's Range | 32.01 - 33.20 |
| Day's Volume | 5,605,162 |
| 52-Week Range | 18.37 - 34.81 |
Elanco Animal Health Inc (NYSE: ELAN) has reported Q1 EPS of $0.37 higher than $0.13 reported a year ago. It surpassed analysts' estimate of $0.23 and beat the company guidance of $0.20 - $0.25.
Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 60.87% and 7.36%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for th...
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today reported strong financial results for the first quarter of 2021, provided guidance for the second quarter of 2021,...
Varied companies across the vast healthcare space might have been affected differently by the COVID crisis during the first quarter.
Elanco (ELAN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Elanco Animal Health Introduces First Oral Flea and Tick Product for Cats, Credelio® CAT (lotilaner)
GREENFIELD, Ind.--(BUSINESS WIRE)--Veterinarians in the U.S. now have a new, innovative option for flea and tick control as Elanco Animal Health Incorporated (NYSE: ELAN) introduces Credelio Cat, the fi...
Elanco Animal Health Incorporated (ELAN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Elanco Animal Health Incorporated (ELAN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Elanco's share price has come under pressure amid new concerns over a key product.
GREENFIELD, Ind.--(BUSINESS WIRE)--Today, Elanco and Ducks Unlimited announced a partnership emphasizing the strong bond between environmental sustainability and agriculture – specifically beef cattle p...
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will announce its first quarter 2021 financial results on Friday, May 7, 2021. Elanco will also conduct a conference cal...
NEW YORK, April 6, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or the "Company") (NYSE: ELAN). Such investors are ad...
Here's how you can profit off the booming $54 billion veterinary care industry.
NEW YORK, March 30, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or the "Company") (NYSE: ELAN). Such investors are a...
Elanco Animal Health aims to tackle the noxious problem of ammonia emissions in livestock farming.
TAMPA, FL and RESEARCH TRIANGLE PARK, NC / ACCESSWIRE / March 23, 2021 / The Mosaic Company (NYSE:MOS), one of the world's leading producers and marketers of concentrated phosphate and potash crop nutri...
GREENFIELD, Ind.--(BUSINESS WIRE)--Based on recent misleading media coverage, a U.S. House of Representatives subcommittee chair made a request to Elanco Animal Health, Incorporated (NYSE: ELAN) to temp...
DENVER, March 19, 2021 /PRNewswire/ -- Morris Animal Foundation, a leader in advancing animal health, is partnering with Elanco Animal Health Incorporated (NYSE: ELAN) to better understand the incidence...
Elanco just completed its largest merger ever. Now it turns its attention to ambitious earnings growth goals in 2021.
Elanco Animal Health Incorporated (ELAN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
The stock price of Elanco (NASDAQ: ELAN), a pharmaceuticals company focused on medicines for pets and livestock, has seen a solid 13% rise over the last ten trading days, while it's up 9% over the last ...
Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 33.33% and 8.48%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for...
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today reported its financial results for the fourth quarter and full year of 2020, increased guidance for full year 2021...
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announced the departure of executive vice president Michael-Bryant Hicks (“Hicks”). He joined Elanco in 2018 as Ge...
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announces four important innovation milestones, including two product approvals, amid a string of recent progress ...
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the Cowen 41st Annual Health Care Conference on Tuesday, March 2, 2021. Jeff Simmons, president and ...
Elanco Animal Health Incorporated (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the BofA Securities Animal Health Virtual Summit on Thursday, February 25, 2021. Jeff Simmons, presi...
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will announce its fourth quarter 2020 financial results on Wednesday, February 24, 2021. Elanco will also conduct a conf...
Elanco Announces Next Wave of Restructuring to Drive Operational Efficiencies Post Bayer Acquisition
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announced the next step in its ongoing efforts to improve operational efficiency. The proposed actions are focused...
Elanco is one of a few large, independent animal health companies and this type of company is very hard to build from scratch.
Elanco Animal Health Incorporated (ELAN) CEO Jeffrey Simmons Presents at 39th Annual JPMorgan Virtual Healthcare Brokers Conference (Transcript)
GREENFIELD, Ind.--(BUSINESS WIRE)--Today Elanco Animal Health Incorporated (NYSE: ELAN) announced that executive vice president of Transformation and Technology, Sarena Lin, will take a role outside of ...
Bitcoin, Walgreens, Elanco Animal Health and Garmin were our top stock trades for Thursday. Let's have a look at what the charts are saying.
Elanco outlined its latest financial targets at a recent investor day event. The innovation engine is in full swing, and if it delivers, I see plenty of upside to the conservative top-line targets.
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021. Jeff Simmons, presid...
Spending on pets is a $100 billion industry. Here's how you can take advantage.
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today will host its Investor Day, where the executive leadership team will outline the company's strengthened and expand...
SAN DIEGO, Dec. 15, 2020 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in NYSE: ELAN shares. Investors, who purchased shares of Elanco A...
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announced that it has appointed distinguished healthcare executive, animal health director and investor William F....
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announced an agreement with Kindred Biosciences (NASDAQ: KIN) to acquire exclusive global rights to KIND-030, a fi...
GREENFIELD, Ind.--(BUSINESS WIRE)--After a rigorous multi-state search, Elanco Animal Health, Inc. (NYSE: ELAN) today announced Indiana as its base for future global consolidated operations, anchored by...
Elanco Animal Health, Inc. (ELAN) Presents at Evercore ISI HealthCONx Broker Conference Call - (Transcript)
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announced that it will host a virtual investor day on Tuesday, December 15, 2020. The event will feature presentat...
Elanco Animal Health Inc (NYSE: ELAN) in a filing with the U.S. Securities and Exchange Commission on Monday disclosed that German pharma and life sciences company Bayer AG (OTC: BAYRY) is offloading a ...
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announced the pricing of the previously announced public offering of 54,500,000 shares of its common stock held by...
About ELAN
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticid... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | IPO Date Sep 20, 2018 |
| Stock Exchange NYSE | Ticker Symbol ELAN |
Analyst Forecasts
According to 16 analysts, the average rating for ELAN stock is "Buy." The 12-month stock price forecast is 33.82, which is an increase of 2.86% from the latest price.